A&O Shearman
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Renowned for its proficiency in high-profile patent litigation and big-ticket transactions – including M&A, licensing and collaborations – A&O Shearman advises across the full spectrum of life sciences, supporting global pharmaceutical, growth-stage and consumer healthcare companies. The ‘professional, efficient and effective’ team also handles regulatory, antitrust, employment, and investigations matters. The practice is jointly led by Matthew Appleton, noted for his ’innovative’ transaction structuring; Jim Ford, IP and commercial specialist at the forefront of AI and machine learning in drug development; and Marjan Noor, an expert in life sciences patents and regulatory law. Rafi Allos focuses on contentious patent matters and regulatory advice, while Megan McMellon combines expertise in cross-border IP transactions and commercial agreements. The team’s IP capabilities were strengthened by the arrival of Gemma Barrett from Bristows LLP in February 2024.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Jim Ford and Megan McMellon and their team persistently carry out risk assessments and propose the optimal structure even when we propose a highly complex transaction structure. They are persistent in dealing with projects that seem very difficult to carry out. They are always there for the clients. ’
- ‘Marjan Noor and Tom Edwards are excellent.’
Key clients
- Bayer
- Exscientia